These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23340892)

  • 1. Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Matsumoto S; Mineoka Y; Nakanishi N; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Diabetes Care; 2013 Jul; 36(7):1908-12. PubMed ID: 23340892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A difference in systolic blood pressure between arms is a novel predictor of the development and progression of diabetic nephropathy in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Matsumoto S; Iwase H; Kobayashi K; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2013 Oct; 230(2):198-201. PubMed ID: 24075744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Inada S; Mineoka Y; Nakanishi N; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2012 Jan; 220(1):155-9. PubMed ID: 22100253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus.
    Ushigome E; Fukui M; Hamaguchi M; Senmaru T; Sakabe K; Tanaka M; Yamazaki M; Hasegawa G; Nakamura N
    Hypertens Res; 2011 Dec; 34(12):1271-5. PubMed ID: 21814212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes.
    Takao T; Matsuyama Y; Yanagisawa H; Kikuchi M; Kawazu S
    J Diabetes Complications; 2014; 28(2):185-90. PubMed ID: 24332763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A difference in systolic blood pressure between arms and between lower limbs is a novel risk marker for diabetic nephropathy in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Matsumoto S; Mineoka Y; Nakanishi N; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Hypertens Res; 2013 May; 36(5):403-7. PubMed ID: 23324865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
    Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
    Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of diabetic renal function impairment in the first decade after diagnosed of diabetes mellitus is correlated with high variability of visit-to-visit systolic and diastolic blood pressure: a case control study.
    Yeh CH; Yu HC; Huang TY; Huang PF; Wang YC; Chen TP; Yin SY
    BMC Nephrol; 2017 Mar; 18(1):99. PubMed ID: 28330451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive ability of visit-to-visit variability in HbA1c and systolic blood pressure for the development of microalbuminuria and retinopathy in people with type 2 diabetes.
    Takao T; Suka M; Yanagisawa H; Matsuyama Y; Iwamoto Y
    Diabetes Res Clin Pract; 2017 Jun; 128():15-23. PubMed ID: 28432895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
    McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
    Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of blood pressure variability in the development of nephropathy in type 1 diabetes.
    Kilpatrick ES; Rigby AS; Atkin SL
    Diabetes Care; 2010 Nov; 33(11):2442-7. PubMed ID: 20798339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal home SBP targets for preventing the progression of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Ushigome E; Hamaguchi M; Matsumoto S; Oyabu C; Omoto A; Tanaka T; Fukuda W; Hasegawa G; Mogami S; Ohnishi M; Kitagawa Y; Tsunoda S; Oda Y; Nakamura N; Fukui M
    J Hypertens; 2015 Sep; 33(9):1853-9; discussion 1859. PubMed ID: 26136206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visit-to-visit HbA1c variability and systolic blood pressure (SBP) variability are significantly and additively associated with mortality in individuals with type 1 diabetes: An observational study.
    Wightman SS; Sainsbury CAR; Jones GC
    Diabetes Obes Metab; 2018 Apr; 20(4):1014-1017. PubMed ID: 29266630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
    Ceriello A; De Cosmo S; Rossi MC; Lucisano G; Genovese S; Pontremoli R; Fioretto P; Giorda C; Pacilli A; Viazzi F; Russo G; Nicolucci A;
    Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
    Hata J; Arima H; Rothwell PM; Woodward M; Zoungas S; Anderson C; Patel A; Neal B; Glasziou P; Hamet P; Mancia G; Poulter N; Williams B; Macmahon S; Chalmers J;
    Circulation; 2013 Sep; 128(12):1325-34. PubMed ID: 23926207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home Blood Pressure Variability From the Stored Memory Is Correlated With Albuminuria, but From the Logbook Is not.
    Matsumoto S; Ushigome E; Matsushita K; Fukuda T; Mitsuhashi K; Majima S; Hasegawa G; Nakamura N; Ushigome H; Yamazaki M; Fukui M
    Am J Hypertens; 2017 Oct; 30(10):993-998. PubMed ID: 28911025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of visit-to-visit systolic blood pressure variability related to diabetic kidney disease among patients with type 2 diabetes.
    Yu ZB; Wang JB; Li D; Chen XY; Lin HB; Chen K
    J Hypertens; 2019 Jul; 37(7):1411-1418. PubMed ID: 30640884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visit-to-visit blood pressure variability is related to albuminuria variability and progression in patients with type 2 diabetes.
    Noshad S; Mousavizadeh M; Mozafari M; Nakhjavani M; Esteghamati A
    J Hum Hypertens; 2014 Jan; 28(1):37-43. PubMed ID: 23863801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of day-by-day variability of home blood pressure on progression to macroalbuminuria in patients with diabetes.
    Ushigome E; Matsumoto S; Oyabu C; Kitagawa N; Tanaka T; Hasegawa G; Ohnishi M; Tsunoda S; Ushigome H; Yokota I; Nakamura N; Oda Y; Asano M; Tanaka M; Yamazaki M; Fukui M
    J Hypertens; 2018 May; 36(5):1068-1075. PubMed ID: 29283972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure).
    Imai E; Ito S; Haneda M; Harada A; Kobayashi F; Yamasaki T; Makino H; Chan JC
    Nephrol Dial Transplant; 2016 Mar; 31(3):447-54. PubMed ID: 26152402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.